Safety of daprodustat in patients with anemia of chronic kidney disease: A pooled analysis of phase 3 studies in Japan.

Masaomi NangakuTadao AkizawaTakashi NagakuboTaeko YonekawaToshifumi KimuraYukihiro EndoAlexander Cobitz

Published in: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy (2022)

The safety of daprodustat was comparable to ESA in this pooled analysis, although further large-scale research is needed to evaluate long-term risks including cardiovascular and malignancy events.

Keyphrases

chronic kidney disease
end stage renal disease
risk assessment
iron deficiency
peritoneal dialysis
climate change
study protocol
phase iii
double blind